Vaishali Pharma Limited - Asset Resilience Ratio

Latest as of September 2025: 25.30%

Vaishali Pharma Limited (VAISHALI) has an Asset Resilience Ratio of 25.30% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check VAISHALI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs308.48 Million

≈ $3.34 Million USD Cash + Short-term Investments

Total Assets

Rs1.22 Billion

≈ $13.19 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Vaishali Pharma Limited's Asset Resilience Ratio has changed over time. See Vaishali Pharma Limited balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Vaishali Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Vaishali Pharma Limited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs10.46 Million	0.86%
Short-term Investments	Rs298.02 Million	24.44%
Total Liquid Assets	Rs308.48 Million	25.30%

Asset Resilience Insights

Very High Liquidity: Vaishali Pharma Limited maintains exceptional liquid asset reserves at 25.30% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Vaishali Pharma Limited Industry Peers by Asset Resilience Ratio

Compare Vaishali Pharma Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Vaishali Pharma Limited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Vaishali Pharma Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	27.42%	Rs301.23 Million ≈ $3.26 Million	Rs1.10 Billion ≈ $11.88 Million	+25.11pp
2024-03-31	2.31%	Rs18.50 Million ≈ $200.09K	Rs799.56 Million ≈ $8.65 Million	-14.01pp
2023-03-31	16.32%	Rs128.79 Million ≈ $1.39 Million	Rs789.07 Million ≈ $8.53 Million	+0.13pp
2022-03-31	16.19%	Rs132.16 Million ≈ $1.43 Million	Rs816.24 Million ≈ $8.83 Million	+1.93pp
2021-03-31	14.26%	Rs122.79 Million ≈ $1.33 Million	Rs861.23 Million ≈ $9.31 Million	+16.90pp
2020-03-31	-2.64%	Rs-17.50 Million ≈ $-189.22K	Rs662.04 Million ≈ $7.16 Million	+1.58pp
2019-03-31	-4.22%	Rs-29.00 Million ≈ $-313.66K	Rs687.51 Million ≈ $7.44 Million	-19.56pp
2018-03-31	15.34%	Rs98.66 Million ≈ $1.07 Million	Rs643.23 Million ≈ $6.96 Million	+15.78pp
2017-03-31	-0.44%	Rs-1.98 Million ≈ $-21.40K	Rs446.49 Million ≈ $4.83 Million	-1.02pp
2016-03-31	0.58%	Rs2.88 Million ≈ $31.16K	Rs497.73 Million ≈ $5.38 Million	--

pp = percentage points

About Vaishali Pharma Limited

NSE:VAISHALI India Drug Manufacturers - Specialty & Generic

Market Cap

$10.82 Million

Rs1.00 Billion INR

Market Cap Rank

#26848 Global

#1502 in India

Share Price

Rs7.67

Change (1 day)

+2.95%

52-Week Range

Rs4.88 - Rs13.15

All Time High

Rs42.57